Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Elara MD vs FitFlow

Elara MD
Graded #467

Lower grade

vs+14.099999999999994
FitFlow
Graded #166

Higher grade

The verdict

FitFlow takes it — 67.6/100 to 53.5/100.

FitFlow grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FitFlow (FitFlow Health) is a 100% online compounded telehealth platform for GLP-1 weight loss - compounded semaglutide (=Wegovy) and tirzepatide (=Mounjaro).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFitFlow +17
40
57
Dose & formulationFitFlow +23
54
77
Clinical oversightFitFlow +22
63
85
Labs & monitoringFitFlow +3
52
55
FulfillmentFitFlow +15
66
81
Contract termsElara MD +18
55
37
Elara MD · left barFitFlow · right bar

The numbers

MetricElara MDFitFlow
WeighScore53.5/10067.6/100
GradeCC
Scorecard rank#467#166
Semaglutide$249/mo (0.2 mg dose, compounded)$175/mo (compounded)
Tirzepatide$349/mo (2.0 mg dose, compounded)$235/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Elara MD

Graded #467 · C

Strengths

  • Dose-banded monthly pricing published on-site ($249–$649/mo across tiers)
  • Both a semaglutide-range and a tirzepatide-range (GLP-1/GIP) option, plus microdosing
  • Medication included in the monthly price with free fast shipping when prescribed
  • Broad reach claimed (over 40 states)

Where it loses points

  • Molecules not named on-site (only 'Personalized GLP-1') — compounded status is inferred
  • No FDA compounded-medication disclaimer published
  • No named compounding pharmacy partner — prescriptions are patient-directed
  • LegitScript certification, medical director, and full state list not disclosed
  • Pricier than several compounded competitors
FitFlow

Graded #166 · C

Strengths

  • Compounded semaglutide (=Wegovy) and tirzepatide (=Mounjaro); month-to-month from $175/$235, or as low as $99/$125 on annual prepay
  • 100% online 4-step process; board-certified provider review in 24-48 hours, with unlimited messaging and dose adjustments
  • Free nationwide shipping (discreet, 5-7 days) from US-licensed compounding pharmacies
  • FSA/HSA eligible with financing (Affirm, Klarna, Afterpay); month-to-month or prepay plans, cancel anytime
  • Transparent 'no hidden fees' pricing; 6,000+ members; same-platform add-ons (NAD+, sermorelin, MIC+B12, glutathione, hair, sexual health)

Where it loses points

  • Headline '$99/$125 a month' requires a full year prepaid upfront ($1,188 / $1,500); true month-to-month is $175 / $235
  • Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • The compounding pharmacy partner is not named ('US-licensed / FDA-regulated pharmacies' only)
  • State-availability list is not published (free nationwide shipping advertised, but no explicit state list)
  • No LegitScript certification displayed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard